Global partnerships formed during the Covid-19 era
Coronavirus brings attention to the fast-growing $35bn vaccine market.
Read more hereNew vaccine delivery technologies for better immune response
Clinical trials show delivery of vaccines via new techniques induce greater immune responses than traditional methods.
Secure your placeExploring new genetic-engineering technologies for vaccine development
Hear the latest case studies in messenger RNA technologies for next-generation vaccines.
View the latest programExpert Speakers to Date
- Yongxiu Yao
The Pirbright Institute - Tom Tillett
MBF Therapeutics - Sushant Sahastrabuddhe
International Vaccine Institute - Kevin Killeen
Matrivax Corporation - Anh Wartel
International Vaccine Institute - Anna Särnefält
CEPI - Jasmin Samaras
University College London - Antonio Roldao
iBET - Philip Probert
Centre for Process Innovation Limited - Gregory Tobin
Biological Mimetics
Past Attendees
- Cytiva (formerly GE Healthcare)
- Biological Mimetics
- MERCK
- CanSino Biologics
- MBF Therapeutics
- Matrivax Corporation
- International Vaccine Institute
- CEPI
- Technical University of Denmark
- The Pirbright Institute
- VBI Vaccines
- CPI
- iBET
- University College London
- Harvard University
- Bill & Melinda Gates Foundation
Who should attend
- Vaccine Research
- Vaccine Development
- Vaccine Manufacturing
- Vaccine Technologies
- Genetic Engineering
- DNA, mRNA Technologies
- Viral Vector-Based Vaccines
- Nucleic Acid-Based Vaccines
- Vaccine Delivery Platforms
- Biological Engineering of Vaccines
- Structural Vaccinology Projects
- Advanced Live-Attenuated Vaccines
- Inactivated Vaccine Development
- Cost Reduction Strategies
- Sales and Marketing Initiatives
- Business Development
- Clinical Trials and Approvals
- Immunization Research & Development
- Manufacturing Research & Innovation
- Research and Development
- Strategy, Projects, & Public Affairs
- Legal and Compliance Work
- Equipment Certification Services
- News Reporting and Journalism
- Biotechnology Companies
- Pharmaceutical Companies
- Vaccination Developers
- Vaccine Researchers
- Vaccine Technology Companies
- Immunization Specialists
- Public Healthcare Providers
- Genetic Engineering Companies
- Global Healthcare Institutions
- Clinical Research Organizations
- Vaccine Delivery Technologies
- Vaccines Manufacturing
- Vaccinology Research & Development
- Biological Engineering Companies
- DNA and Messenger RNA Researchers
- International Quality Standards
- Associations and Alliances
- Universities and Academia
- Research and Development
- Government Agencies
- Consultants and Advisors
- Public Consultation Groups
- Legal and Compliance Services
- News Reporters and Journalists
Why Attend
The Vaccine Technology Summit 2024 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest vaccine technologies and techniques for discovering, developing, and manufacturing next-generation vaccines…
view more...The Premier Forum for Global Vaccine Technologies
Welcome to the Vaccine Technology Summit 2024, where global biotech and pharmaceutical companies will meet with leading vaccine experts in Boston, Massachusetts, to explore new vaccine technologies to discover, develop, and manufacture next-generation vaccines.
As today’s vaccine developers continue to learn from the global outbreak of Covid-19 and diseases of the past, it is of critical importance that leading institutions and experts unite and collaborate in developing cures, from the initial discoveries and clinical trials to the manufacturing process of new vaccines to meet the needs of the human population.
Global vaccine leaders are fast developing a wide array of new technologies, from targeted attenuation techniques to the delivery of biologically engineered proteins, viral vectors, and nucleic acid-based vaccines – many of which have offered promising results for vaccine development.
This year’s Vaccine Technology Summit 2024 is set to become the world’s leading exhibition and conference exclusively for the vaccine industry, to meet and collaborate with a large array of vaccine experts and institutions, to examine new vaccination technologies and technical know-how, and to discuss the fundamental challenges associated with discovery, development, and manufacturing of next-generation vaccines.
Key topics on this year’s agenda include:
- The fundamentals of new vaccine discovery and development
- Exploring new technologies in vaccine delivery for better immune responses
- Latest research in genetically-engineered vaccinations and mRNA vaccine technologies
- New developments in viral vectors, nucleic acid-based vaccines, and structural vaccinology
- Advances in live-attenuated virus vaccines and lessons learned from inactivated vaccines
- Case studies and clinical trials and working with global vaccine manufacturers
This event will provide a forum for all stakeholders across the biotech and pharmaceutical industry, from leading vaccine developers to manufacturers, to network and build cross-market relationships to explore new technologies and technical know-how to address the global challenges in vaccine development.
Call for Presentation
If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading "Call for Papers - Vaccine Technology Summit 2024".
Book now
To secure your place at Vaccine Technology Summit 2024 or if you require more information, please contact delegates@iQ-Hub.com.
Key topics for 2024:
- The fundamentals of new vaccine discovery and development
Understand biotech and pharmaceutical industry fundamentals and key market drivers for developing vaccinations from a global perspective. - Exploring new technologies in vaccine delivery for better immune responses
Look for new opportunities and make the clinical case for adopting new technology and techniques for vaccine delivery. - Latest research in genetically-engineered vaccinations and mRNA vaccine technologies
Explore innovations and assess the latest results from tests and trials in biologically-engineered vaccinations and new advancements in DNA and messenger RNA vaccination technologies. - New developments in viral vectors, nucleic acid-based vaccines, and structural vaccinology
Future vaccination strategies and the latest advancements in viral vector-based applications for adapting structural viral vaccine design and development. - Advances in live-attenuated virus vaccines and lessons learned from inactivated vaccines
Hear from leading vaccine developers and build on traditional vaccine approaches for cost-effective and proven methods for developing new vaccines. - Case studies and clinical trials and working with global vaccine manufacturers
Gain insights from leading manufacturers and implement strategies that others in the industry use to ensure successful vaccine delivery.
Subscribe for updates:
Testimonials
- Highly informational event with lots of opportunities to engage with other people from the field.
Ying Wang, Johnson & Johnson - Excellent speaker line up. Showcasing the science and results from across the industry.
Anne Renton, Merck - Well organized and great discussions. Networking opportunities were excellent.
Carolyn Dulney, Roche - Provided a great learning opportunity and served as a very good networking event.
Mike Zimmer, Novartis - I loved the show! Very informative conference and a great group of people.
Wensheng Du, GlaxoSmithKline - Excellent conference. Very useful information. Well organized event and agenda was very appropriate.
Barry Rosen, Sanofi